Accelerate Diagnostics reported 35.72M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US 35.72M 8.86M
Becton, Dickinson and BDX:US $ 2283M 870M
Bio Rad Laboratories BIO:US $ 859.9M 127.07M
Bruker BRKR:US $ 573M 35.1M
Danaher DHR:US $ 2552M 4770M
Exact Sciences EXAS:US $ 273.78M 89.94M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Hologic HOLX:US $ 1170.3M 342.7M
Illumina ILMN:US $ 1080M 3116M
Luminex LMNX:US $ 271.56M 37.85M
Meridian Bioscience VIVO:US $ 49.77M 48.75M
Myriad Genetics MYGN:US $ 295.2M 176.8M
Nanostring Technologies NSTG:US $ 107.17M 53.21M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Pacific Biosciences Of California PACB:US $ 1079.89M 620.1M
Perkinelmer PKI:US $ 487.37M 85.44M
Quidel QDEL:US $ 578.45M 14.78M
Thermo Fisher Scientific TMO:US $ 12027M 5004M